Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00760851 · ClinicalTrials.gov registry record · Phase 3
Yogurt Study in Children 2-4 Years Old Attending Daycare
A Phase 3 study of Diarrhea and Infections, Respiratory, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 3
- Development phase
- 190
- Enrollment target
- 1
- Study location
NCT00760851 is a Phase 3 study of Diarrhea and Infections, Respiratory that has completed, run by Georgetown University. The registered enrollment target is 190 participants, above the 149-participant average among 24 other Diarrhea trials with a reported enrollment target (28% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00760851, a Phase 3 study of Diarrhea and Infections, Respiratory, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 190 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effectiveness of probiotics (popularly referred to as 'live active culture' or 'good bacteria') in preventing illnesses and consequent absences from school/daycare centers of children two to four years old that attend daycare at least 3 days per week. Two yogurt drinks will be administered, one containing a specific strain of probiotic, Bb-12. It is hypothesized that children receiving the Bb-12 drink will experience fewer illnesses and absences from daycare. In this study, participants will be asked to: 1. Give their child 4 oz. of the test yogurt each day for 90 days 2. Keep a daily diary of their child's health 3. Collect 3 stool samples from their child at the start, middle, and end of the study 4. Speak with research personnel on a bi-weekly basis regarding their child's health 5. Ensure that their child to consume any yogurts or probiotic-containing products for 110 days of the study
Conditions Studied
Interventions
- OTHER probiotic strain Bb-12
- OTHER no Bb-12
Study Locations (1)
District of Columbia
- Georgetown University Department of Family Medicine, Research Division - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00760851
The ClinicalTrials.gov registry entry for NCT00760851 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 149-participant average among 24 other Diarrhea trials with a reported enrollment target (28% higher). The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diarrhea appearing as the primary indexed condition, and to 2 interventions - of which probiotic strain Bb-12 is the first listed.
NCT00760851 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00760851 about?
NCT00760851 is a clinical study titled "Yogurt Study in Children 2-4 Years Old Attending Daycare". The purpose of this study is to determine the effectiveness of probiotics (popularly referred to as 'live active culture' or 'good bacteria') in preventing illnesses and consequent absences from school/daycare centers of children two to four years old that attend daycare at least 3 days per week. Tw...
What is the current status of trial NCT00760851?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 190 participants. The study started on 2008-09. Estimated completion is 2010-07.
What conditions does trial NCT00760851 study?
This clinical trial studies the following conditions: Diarrhea, Infections, Respiratory.
What interventions are being tested in trial NCT00760851?
The interventions under investigation include: probiotic strain Bb-12 (OTHER), no Bb-12 (OTHER).
Who is sponsoring clinical trial NCT00760851?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00760851 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diarrhea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GI Alpha-Gal Study
RECRUITING · NA
-
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
RECRUITING · Phase 4
-
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
RECRUITING · Phase 1
-
Fecal Microbiota Transplantation for IBS
RECRUITING · Phase 2
-
First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults
RECRUITING · Phase 1
-
Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodulator
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.